Holen Sie sich die Stockscreener-App
5.5186
3.96%
-0.2214
Schlusskurs vom Vortag:
$5.74
Offen:
$5.82
24-Stunden-Volumen:
908.30K
Relative Volume:
0.34
Marktkapitalisierung:
$620.90M
Einnahmen:
$1.89B
Nettoeinkommen (Verlust:
$-496.52M
KGV:
-1.1594
EPS:
-4.7598
Netto-Cashflow:
$1.40M
1W Leistung:
+1.71%
1M Leistung:
+30.64%
6M Leistung:
+32.84%
1J Leistung:
-52.64%
1-Tages-Spanne:
$5.49
$5.84
1-Wochen-Bereich:
$5.395
$6.01
52-Wochen-Spanne:
$2.095
$12.03
Evolent Health Inc Stock (EVH) Company Profile
Firmenname
Evolent Health Inc
Sektor
Branche
Telefon
571-389-6000
Adresse
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
5.52 | 642.27M | 1.89B | -496.52M | 1.40M | -4.7598 |
VEEV
Veeva Systems Inc
|
194.20 | 31.31B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
69.00 | 13.55B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
60.62 | 10.82B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
97.95 | 7.97B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
89.78 | 6.50B | 646.34M | -512.40M | 202.76M | -6.6871 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-25 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-11-13 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-03 | Bestätigt | BTIG Research | Buy |
| 2024-11-08 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | Hochstufung | Truist | Hold → Buy |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-01 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-10-16 | Eingeleitet | UBS | Buy |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2022-11-01 | Eingeleitet | Truist | Hold |
| 2022-07-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2021-11-18 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-04-29 | Fortgesetzt | JP Morgan | Neutral |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-07-06 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | Herabstufung | Goldman | Buy → Neutral |
| 2020-06-02 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | Fortgesetzt | Leerink Partners | Outperform |
| 2018-06-04 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-04-24 | Fortgesetzt | JP Morgan | Neutral |
| 2017-09-20 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2017-03-14 | Eingeleitet | Oppenheimer | Outperform |
| 2017-01-13 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | Fortgesetzt | JP Morgan | Overweight |
| 2016-08-05 | Bestätigt | FBR Capital | Outperform |
| 2016-07-26 | Eingeleitet | Jefferies | Buy |
| 2016-07-13 | Bestätigt | FBR Capital | Outperform |
| 2016-03-29 | Eingeleitet | FBR Capital | Outperform |
| 2016-01-06 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-06-30 | Eingeleitet | Goldman | Buy |
| 2015-06-30 | Eingeleitet | JP Morgan | Overweight |
| 2015-06-30 | Eingeleitet | Leerink Partners | Outperform |
| 2015-06-30 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Evolent Health Inc Aktie (EVH) Neueste Nachrichten
Evolent Health (EVH) CEO gets 446,102 RSUs and has shares withheld for taxes - Stock Titan
Evolent Health (EVH) General Counsel receives RSU grant with tax-withholding entry - Stock Titan
Evolent Health (EVH) president receives 302,585 RSUs in equity grant - Stock Titan
Evolent Health (EVH) grants 28,790 RSUs to Chief Accounting Officer - Stock Titan
Evolent Health focuses on value-based care as investors watch long-term growth - AD HOC NEWS
Evolent Health Q1 2026 slides: revenue misses forecast, leverage rises - Investing.com
EVHEvolent Health Inc Options - Finviz
Should you buy Evolent Health (EVH) after golden cross? - MSN
Should You Buy Evolent Health (EVH) After Golden Cross? - Yahoo! Finance Canada
Truist Financial Downgrades Evolent Health(EVH.US) to Hold Rating, Maintains Target Price $7 - Moomoo
Truist cuts Evolent Health stock rating on Medicaid headwinds By Investing.com - Investing.com South Africa
Truist cuts Evolent Health stock rating on Medicaid headwinds - Investing.com
Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength? - Yahoo Finance
EVH Stock On Track To Open At Record Low – Here’s Why Keybanc Turned Cautious - Stocktwits
Enterprise value to EBIT forward of Evolent Health Inc Class A – FWB:9EH - TradingView
Price to sales forward of Evolent Health, Inc – NYSE:EVH - TradingView
Price to sales forward of Evolent Health Inc Class A – FWB:9EH - TradingView
Price to earnings forward of Evolent Health, Inc – NYSE:EVH - TradingView
Evolent Health Inc (EVH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Evolent Health quarterly loss narrows, shares react to value-based care focus - AD HOC NEWS
Discipline and Rules-Based Execution in EVH Response - Stock Traders Daily
Evolent Health Inc Class A Actuals & Estimates (NYSE:EVH) - TradingView
EVH Forecast — Price Target — Prediction for 2027 - TradingView
Citigroup Maintains Evolent Health (EVH) Buy Recommendation - MSN
Evolent Health Inc (EVH) Institutional Confidence - TradingKey
Evolent Health Inc (EVH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Evolent Health Inc (EVH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Evolent Health Inc (EVH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Evolent Health Inc (EVH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Evolent Health Inc (EVH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Evolent Health Inc (EVH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Evolent Health Inc (EVH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Evolent Health Leads Healthcare Technology Sector Focus - Kalkine Media
Q1 2026 Earnings Season Results for Healthcare Technology for Providers StocksNews and Statistics - IndexBox
Q1 Earnings Outperformers: Evolent Health (NYSE:EVH) And The Rest Of The Healthcare Technology for Providers Stocks - Yahoo Finance
Truist Financial Maintains Evolent Health(EVH.US) With Buy Rating, Announces Target Price $7 - Moomoo
Evolent Health | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo
Director Toyin Ajayi granted 41,096 RSUs at Evolent Health (EVH) - Stock Titan
Evolent Health (EVH) director Russell Glass receives 41,096 restricted stock units - Stock Titan
Evolent Health (EVH) director receives 41,096 restricted stock units grant - Stock Titan
[Form 4] Evolent Health, Inc. Insider Trading Activity - Stock Titan
Evolent Health (EVH) director receives 41,096 restricted stock units in equity grant - Stock Titan
Evolent Health (EVH) director Kim Keck granted 41,096 restricted stock units - Stock Titan
Evolent Health (EVH) director receives 41,096 restricted stock units award - Stock Titan
Director at Evolent Health (EVH) receives 41,096-share RSU grant - Stock Titan
Equity grant lifts Evolent (NYSE: EVH) director Barbarosh holdings - Stock Titan
Evolent Health Inc stock (US30050B1017): valuation metrics in focus after recent share price recover - AD HOC NEWS
Evolent Health Shareholders Approve Proposals at 2026 Meeting - The Globe and Mail
Evolent Health (EVH) holders back board, auditor and pay plan at 2026 meeting - Stock Titan
Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025 - Quantisnow
3 Healthcare Stocks We Approach with Caution - Yahoo Finance
Finanzdaten der Evolent Health Inc-Aktie (EVH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.15%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):